Covid-19: RISC-19-ICU Registry, endorsed by the Swiss Society of Intensive Care Medicine 2021 - 2022
- Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
- Total publications:0 publications
Grant number: 0142004932
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$362,692.36Funder
State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)Principal Investigator
Abteilung Übertragbare Krankheiten Sekretariat derResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Since March 2020, the Institute of Intensive Care Medicine at the University of Zurich has been using the RISC-19-ICU Register to collect detailed data on the physiological and therapy-associated characteristics of patients admitted to an intensive care unit, the course of these characteristics during intensive care, and the clinical outcome. In addition to the direct relevance of the register for the medical understanding of Covid-19 and for the effects of measures (such as the vaccination campaign), these data, which are representative across Switzerland and for various hospital types, in combination with epidemiological data, offer a quantitative insight into developments in intensive care units. In order to ensure our own knowledge needs in adaptation to the changing epidemiological situation, the "continuation of the register for the ongoing monitoring of critically ill COVID-19 patients in Swiss intensive care units" is therefore being planned.